| Financial Year |
March 31 2023 |
| Monetary Funds |
127,721,417.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,417,646.11 |
| Accounts Receivable |
335,008,087.49 |
| Advances to Suppliers |
55,090,114.13 |
| Other Receivables |
11,419,386.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
484,985,157.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,036,236.28 |
| Total Current Assets |
1,226,657,520.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,821,484.92 |
| Investment Properties |
9,275,094.43 |
| Fixed Assetes |
1,056,970,791.47 |
| Under-construction Projects |
32,038,398.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,148,599.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,671,569.24 |
| Deferred Income Tax Assets |
17,215,930.81 |
| Other Non-Current Assets |
27,091,968.22 |
| Sub-Total of Non-Current Assets |
1,372,109,864.04 |
| Total Assets |
2,598,767,384.25 |
| Short-Term Loans |
431,293,983.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
106,160,809.54 |
| Accounts Payable |
489,474,561.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,358,431.50 |
| Taxes Payable |
20,615,295.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,377,896.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
231,898,950.65 |
| Other Current Liabilities |
6,699,388.13 |
| Sub-Total of Current Liabilities |
1,358,512,331.31 |
| Long-term Loans |
45,063,250.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
94,943,520.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,773,327.48 |
| Deferred Income Tax Liabilities |
4,446,263.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
187,687,365.16 |
| Total Liabilities |
1,546,199,696.47 |
| Paid-In Capital(Or Share Stock) |
651,636,241.00 |
| Capital Surplus |
49,747,220.83 |
| Surplus Reserve |
55,783,625.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
291,102,831.34 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,052,567,687.78 |
| Owner's Equity（Stockholder's Equity） |
1,052,567,687.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,598,767,384.25 |
